文献速递心力衰竭与心肌病

抑制MicroRNA-146a或过表达其靶点DLST可对抗压力负荷诱导的心脏肥厚与功能障碍

Inhibition of MicroRNA-146a and Overexpression of Its Target Dihydrolipoyl Succinyltransferase Protect Against Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction.
PubMed 文献 · Circulation · 2017-06-13

研究在小鼠压力负荷模型(血管紧张素II输注或主动脉缩窄)及主动脉瓣狭窄患者左室活检中观察microRNA-146a变化,发现其上调;心肌细胞过表达microRNA-146a诱发肥厚和左室功能障碍,而基因敲除或药物阻断可减轻肥厚和功能障碍;机制涉及靶点DLST(α-酮戊二酸脱氢酶复合体E2亚基)下调及氧化代谢降低,过表达DLST具有保护作用。

要点

  • microRNA-146a在多种小鼠压力负荷模型全心脏组织中上调,主动脉瓣狭窄患者左室活检中亦中度升高。
  • 心肌细胞过表达microRNA-146a诱发心脏肥厚和左室功能障碍,基因敲除或药物阻断则减轻肥厚反应和功能障碍。
  • microRNA-146a下调靶点DLST,压力负荷下DLST蛋白显著降低伴氧化代谢下降;过表达DLST可保护心脏。

核心结论

  • microRNA-146a及其靶点DLST是左室功能障碍中的重要代谢参与者。
  • 抑制microRNA-146a或过表达DLST可对抗压力负荷诱导的心脏肥厚与功能障碍。

研究设计与样本

  • 小鼠接受血管紧张素II输注或主动脉缩窄建立压力负荷模型。
  • 通过基因敲除、药物阻断或基因过表达调控心肌细胞microRNA-146a,并通过腺相关病毒过表达DLST。
  • 检测小鼠全心脏组织和主动脉瓣狭窄患者左室活检中microRNA-146a水平。

主要发现

  • microRNA-146a在多种小鼠压力负荷模型全心脏组织中上调,在主动脉瓣狭窄患者左室活检中中度增加。
  • 心肌细胞过表达microRNA-146a诱发心脏肥厚和左室功能障碍。
  • 基因敲除或药物阻断microRNA-146a减轻肥厚反应和左室功能障碍。
  • microRNA-146a下调靶点DLST(α-酮戊二酸脱氢酶复合体E2亚基,三羧酸循环限速酶)。
  • 野生型小鼠压力负荷下DLST蛋白显著降低伴氧化代谢下降,microRNA-146a敲除小鼠DLST蛋白和氧化代谢部分维持。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cardiovascular diseases remain the predominant cause of death worldwide, with the prevalence of heart failure continuing to increase. Despite increased knowledge of the metabolic alterations that occur in heart failure, novel therapies to treat the observed metabolic disturbances are still lacking. METHODS: Mice were subjected to pressure overload by means of angiotensin-II infusion or transversal aortic constriction. MicroRNA-146a was either genetically or pharmacologically knocked out or genetically overexpressed in cardiomyocytes. Furthermore, overexpression of dihydrolipoyl succinyltransferase (DLST) in the murine heart was performed by means of an adeno-associated virus. RESULTS: MicroRNA-146a was upregulated in whole heart tissue in multiple murine pressure overload models. Also, microRNA-146a levels were moderately increased in left ventricular biopsies of patients with aortic stenosis. Overexpression of microRNA-146a in cardiomyocytes provoked cardiac hypertrophy and left ventricular dysfunction in vivo, whereas genetic knockdown or pharmacological blockade of microRNA-146a blunted the hypertrophic response and attenuated cardiac dysfunction in vivo. Mechanistically, microRNA-146a reduced its target DLST-the E2 subcomponent of the α-ketoglutarate dehydrogenase complex, a rate-controlling tricarboxylic acid cycle enzyme. DLST protein levels significantly decreased on pressure overload in wild-type mice, paralleling a decreased oxidative metabolism, whereas DLST protein levels and hence oxidative metabolism were partially maintained in microRNA-146a knockout mice. Moreover, overexpression of DLST in wild-type mice protected against cardiac hypertrophy and dysfunction in vivo. CONCLUSIONS: Altogether we show that the microRNA-146a and its target DLST are important metabolic players in left ventricular dysfunction.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Heggermont WA, Papageorgiou AP, Quaegebeur A, et al. Inhibition of MicroRNA-146a and Overexpression of Its Target Dihydrolipoyl Succinyltransferase Protect Against Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction. Circulation. 2017. PMID: 28611091. doi:10.1161/CIRCULATIONAHA.116.024171

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。